Cargando…

Stereotactic Radiotherapy for the Management of Refractory Ventricular Tachycardia: Promise and Future Directions

Ventricular tachycardia (VT) caused by myocardial scaring bears a significant risk of mortality and morbidity. Antiarrhythmic drug therapy (AAD) and catheter ablation remain the cornerstone of VT management, but both treatments have limited efficacy and potential adverse effects. Stereotactic body r...

Descripción completa

Detalles Bibliográficos
Autores principales: Jumeau, Raphael, Ozsahin, Mahmut, Schwitter, Juerg, Elicin, Olgun, Reichlin, Tobias, Roten, Laurent, Andratschke, Nicolaus, Mayinger, Michael, Saguner, Ardan M., Steffel, Jan, Blanck, Oliver, Vozenin, Marie-Catherine, Moeckli, Raphael, Zeverino, Michele, Vallet, Véronique, Herrera-Siklody, Claudia, Pascale, Patrizio, Bourhis, Jean, Pruvot, Etienne
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7329991/
https://www.ncbi.nlm.nih.gov/pubmed/32671101
http://dx.doi.org/10.3389/fcvm.2020.00108
_version_ 1783553013970894848
author Jumeau, Raphael
Ozsahin, Mahmut
Schwitter, Juerg
Elicin, Olgun
Reichlin, Tobias
Roten, Laurent
Andratschke, Nicolaus
Mayinger, Michael
Saguner, Ardan M.
Steffel, Jan
Blanck, Oliver
Vozenin, Marie-Catherine
Moeckli, Raphael
Zeverino, Michele
Vallet, Véronique
Herrera-Siklody, Claudia
Pascale, Patrizio
Bourhis, Jean
Pruvot, Etienne
author_facet Jumeau, Raphael
Ozsahin, Mahmut
Schwitter, Juerg
Elicin, Olgun
Reichlin, Tobias
Roten, Laurent
Andratschke, Nicolaus
Mayinger, Michael
Saguner, Ardan M.
Steffel, Jan
Blanck, Oliver
Vozenin, Marie-Catherine
Moeckli, Raphael
Zeverino, Michele
Vallet, Véronique
Herrera-Siklody, Claudia
Pascale, Patrizio
Bourhis, Jean
Pruvot, Etienne
author_sort Jumeau, Raphael
collection PubMed
description Ventricular tachycardia (VT) caused by myocardial scaring bears a significant risk of mortality and morbidity. Antiarrhythmic drug therapy (AAD) and catheter ablation remain the cornerstone of VT management, but both treatments have limited efficacy and potential adverse effects. Stereotactic body radiotherapy (SBRT) is routinely used in oncology to treat non-invasively solid tumors with high precision and efficacy. Recently, this technology has been evaluated for the treatment of VT. This review presents the basic underlying principles, proof of concept, and main results of trials and case series that used SBRT for the treatment of VT refractory to AAD and catheter ablation.
format Online
Article
Text
id pubmed-7329991
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-73299912020-07-14 Stereotactic Radiotherapy for the Management of Refractory Ventricular Tachycardia: Promise and Future Directions Jumeau, Raphael Ozsahin, Mahmut Schwitter, Juerg Elicin, Olgun Reichlin, Tobias Roten, Laurent Andratschke, Nicolaus Mayinger, Michael Saguner, Ardan M. Steffel, Jan Blanck, Oliver Vozenin, Marie-Catherine Moeckli, Raphael Zeverino, Michele Vallet, Véronique Herrera-Siklody, Claudia Pascale, Patrizio Bourhis, Jean Pruvot, Etienne Front Cardiovasc Med Cardiovascular Medicine Ventricular tachycardia (VT) caused by myocardial scaring bears a significant risk of mortality and morbidity. Antiarrhythmic drug therapy (AAD) and catheter ablation remain the cornerstone of VT management, but both treatments have limited efficacy and potential adverse effects. Stereotactic body radiotherapy (SBRT) is routinely used in oncology to treat non-invasively solid tumors with high precision and efficacy. Recently, this technology has been evaluated for the treatment of VT. This review presents the basic underlying principles, proof of concept, and main results of trials and case series that used SBRT for the treatment of VT refractory to AAD and catheter ablation. Frontiers Media S.A. 2020-06-25 /pmc/articles/PMC7329991/ /pubmed/32671101 http://dx.doi.org/10.3389/fcvm.2020.00108 Text en Copyright © 2020 Jumeau, Ozsahin, Schwitter, Elicin, Reichlin, Roten, Andratschke, Mayinger, Saguner, Steffel, Blanck, Vozenin, Moeckli, Zeverino, Vallet, Herrera-Siklody, Pascale, Bourhis and Pruvot. http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Cardiovascular Medicine
Jumeau, Raphael
Ozsahin, Mahmut
Schwitter, Juerg
Elicin, Olgun
Reichlin, Tobias
Roten, Laurent
Andratschke, Nicolaus
Mayinger, Michael
Saguner, Ardan M.
Steffel, Jan
Blanck, Oliver
Vozenin, Marie-Catherine
Moeckli, Raphael
Zeverino, Michele
Vallet, Véronique
Herrera-Siklody, Claudia
Pascale, Patrizio
Bourhis, Jean
Pruvot, Etienne
Stereotactic Radiotherapy for the Management of Refractory Ventricular Tachycardia: Promise and Future Directions
title Stereotactic Radiotherapy for the Management of Refractory Ventricular Tachycardia: Promise and Future Directions
title_full Stereotactic Radiotherapy for the Management of Refractory Ventricular Tachycardia: Promise and Future Directions
title_fullStr Stereotactic Radiotherapy for the Management of Refractory Ventricular Tachycardia: Promise and Future Directions
title_full_unstemmed Stereotactic Radiotherapy for the Management of Refractory Ventricular Tachycardia: Promise and Future Directions
title_short Stereotactic Radiotherapy for the Management of Refractory Ventricular Tachycardia: Promise and Future Directions
title_sort stereotactic radiotherapy for the management of refractory ventricular tachycardia: promise and future directions
topic Cardiovascular Medicine
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7329991/
https://www.ncbi.nlm.nih.gov/pubmed/32671101
http://dx.doi.org/10.3389/fcvm.2020.00108
work_keys_str_mv AT jumeauraphael stereotacticradiotherapyforthemanagementofrefractoryventriculartachycardiapromiseandfuturedirections
AT ozsahinmahmut stereotacticradiotherapyforthemanagementofrefractoryventriculartachycardiapromiseandfuturedirections
AT schwitterjuerg stereotacticradiotherapyforthemanagementofrefractoryventriculartachycardiapromiseandfuturedirections
AT elicinolgun stereotacticradiotherapyforthemanagementofrefractoryventriculartachycardiapromiseandfuturedirections
AT reichlintobias stereotacticradiotherapyforthemanagementofrefractoryventriculartachycardiapromiseandfuturedirections
AT rotenlaurent stereotacticradiotherapyforthemanagementofrefractoryventriculartachycardiapromiseandfuturedirections
AT andratschkenicolaus stereotacticradiotherapyforthemanagementofrefractoryventriculartachycardiapromiseandfuturedirections
AT mayingermichael stereotacticradiotherapyforthemanagementofrefractoryventriculartachycardiapromiseandfuturedirections
AT sagunerardanm stereotacticradiotherapyforthemanagementofrefractoryventriculartachycardiapromiseandfuturedirections
AT steffeljan stereotacticradiotherapyforthemanagementofrefractoryventriculartachycardiapromiseandfuturedirections
AT blanckoliver stereotacticradiotherapyforthemanagementofrefractoryventriculartachycardiapromiseandfuturedirections
AT vozeninmariecatherine stereotacticradiotherapyforthemanagementofrefractoryventriculartachycardiapromiseandfuturedirections
AT moeckliraphael stereotacticradiotherapyforthemanagementofrefractoryventriculartachycardiapromiseandfuturedirections
AT zeverinomichele stereotacticradiotherapyforthemanagementofrefractoryventriculartachycardiapromiseandfuturedirections
AT valletveronique stereotacticradiotherapyforthemanagementofrefractoryventriculartachycardiapromiseandfuturedirections
AT herrerasiklodyclaudia stereotacticradiotherapyforthemanagementofrefractoryventriculartachycardiapromiseandfuturedirections
AT pascalepatrizio stereotacticradiotherapyforthemanagementofrefractoryventriculartachycardiapromiseandfuturedirections
AT bourhisjean stereotacticradiotherapyforthemanagementofrefractoryventriculartachycardiapromiseandfuturedirections
AT pruvotetienne stereotacticradiotherapyforthemanagementofrefractoryventriculartachycardiapromiseandfuturedirections